分子生药学

4、植物基因的转化技术有哪些?
教材：
分子生药学黄璐琦北京医科大学出版社
主要参考书：
1.植物分子生物技术应用手册/生物实验室系列彭学贤化学工业出版社
2.现代生药学/华夏英才基金学术文库李萍科学出版社
3.中草药生物技术（精）唐克轩复旦大学出版社
4.DNA分子标记技术在植物研究中的应用周延清化学工业出版社
5.分子生药学黄璐琦北京医科大学出版社
6•《中华人民共和国药典》（2010年版一部）
7.《中药材显微鉴别彩色图鉴》注：每门课程都须填写此表。

本表不够可加页。

分子生药学英文Molecular Pharmacology: A Profound Exploration of the Microscopic MarvelsIn the intricate tapestry of the human body, a symphony of molecular interactions orchestrates the delicate balance that sustains our well-being. Molecular pharmacology, a discipline at the forefront of modern medicine, delves into the hidden world of these microscopic marvels, unraveling the complex mechanisms that govern the ways in which drugs and other therapeutic agents interact with the body. This captivating field offers a glimpse into the inner workings of the human organism, paving the way for more targeted and effective treatments.At the heart of molecular pharmacology lies the study of the intricate dance between drugs and their target biomolecules. These biomolecules, often proteins or nucleic acids, play crucial roles in the body's physiological processes. When a drug binds to its target, it can either enhance or inhibit the biomolecule's function, leading to the desired therapeutic effect. By understanding the precise nature of these drug-target interactions, researchers can design more potent and selective drugs, minimizing side effects and maximizingthe therapeutic benefits.One of the cornerstones of molecular pharmacology is the investigation of drug receptor interactions. Receptors are specialized proteins found on the surface of cells or within their interiors, which serve as the primary targets for many drugs. When a drug binds to its receptor, it can trigger a cascade of cellular responses, ultimately leading to the desired therapeutic outcome. Researchers in this field employ advanced techniques, such as X-ray crystallography and molecular modeling, to study the intricate three-dimensional structures of these receptors and the way they interact with different drug molecules.Another crucial aspect of molecular pharmacology is the exploration of drug metabolism and pharmacokinetics. This area examines how the body absorbs, distributes, metabolizes, and eliminates drugs, providing valuable insights into the drug's fate within the human system. By understanding these processes, researchers can optimize drug dosing, improve bioavailability, and minimize the risk of adverse effects. Techniques like mass spectrometry and enzyme kinetics are used to analyze the complex metabolic pathways that drugs undergo, enabling the development of more effective and safer therapeutic interventions.Advances in molecular biology and genetics have further expandedthe horizons of molecular pharmacology. The field now encompasses the study of how genetic variations can influence an individual's response to drugs, a concept known as pharmacogenomics. By identifying genetic markers associated with drug sensitivity or resistance, researchers can tailor treatments to individual patients, ushering in an era of personalized medicine. This approach holds immense promise in improving therapeutic outcomes and reducing the risk of adverse drug reactions.Moreover, molecular pharmacology plays a pivotal role in the development of novel therapeutic agents. From small-molecule drugs to biopharmaceuticals, such as monoclonal antibodies and gene therapies, this discipline provides the foundational knowledge and tools necessary for the rational design and optimization of these cutting-edge treatments. By understanding the intricate mechanisms underlying disease pathogenesis, researchers can target specific molecular pathways and develop more effective and targeted therapies.The impact of molecular pharmacology extends beyond the realm of drug development. This field also contributes to the understanding of the fundamental biological processes that underlie human health and disease. By elucidating the molecular mechanisms involved in the pathogenesis of various disorders, researchers can identify new therapeutic targets and develop innovative approaches to diseasemanagement.As the field of molecular pharmacology continues to evolve, it holds the promise of revolutionizing the way we approach healthcare. By harnessing the power of these microscopic marvels, researchers and clinicians can design more personalized and effective treatments, ultimately improving the quality of life for patients around the world. The journey of molecular pharmacology is one of unraveling the complexities of the human body, unlocking the secrets of disease, and paving the way for a future where targeted, individualized care becomes the norm.。

分子生药学一、分子生药学的含义和研究对象（1）生药：指经过简单加工、直接用于医疗保健或制药原料的药材，包括制药中药、民族药和民间药。

•中药－在中医理论指导下，按照中医的治疗原则使用，并被收载于我国本草著作中的药物。

民间药－指民间医生用于治疗疾病或地区性口耳相传，本草文献无记载，不以中医理论指导的药物。

•民族药－指少数民族使用的、以它们的民族医药理论或传统经验为指导药物。

（2）生药学：利用植物学、动物学、化学等知识，研究生药真伪、优劣等的学科。

研究对象是植物体，植物器官，细胞，化学成分。

•（3）分子生药学：利用分子生物学的理论和方法，研究生药的真伪、优劣的学科。

其研究对象是中药中的DNA，RNA和酶。

二、学习分子生药学的目的意义1. 中药材品种系统整理与质量标准化研究•（1）研究有争议和难鉴定中药材，为确定中药材基源提供理论依据•如黄甘草和胀果甘草的研究，为甘草药材的基源确定提供了依据。

（2）研究有争议的植物类群，促进发现濒危药用植物的替代品。

•基本理论：药用植物亲缘关系越近，形态越相似，化学成分越相近，临床功效越近似，越有可能相互替代。

•当亲缘关系出现争议的时候，可以用分子生药学的方法解决。

例如：•中药材前胡－伞形科前胡属植物白花前胡和紫花前胡的干燥根•紫花前胡－伞形科当归属植物－伞形科前胡属植物•分子证据说明紫花前胡应是当归属植物•2、药用动植物生物多样性保护与生药资源可持续利用研究•研究濒危动植物保护种群的范围•确定物种内基本保护单元是优化和实施保护策略的基础。

•如：海南黑长臂猿是黑长臂猿的亚种；DNA序列差异较大，足以接近种的水平，而且只有15只，被列入最优先保护范围。

3、药用植物分子标记育种与新品种的培育•（1）新品种选育（2）种子种苗纯度鉴定•种子纯度是保证优良品种增产潜力得以发挥的关键因素，保证种子质量具有重要意义。

•田间试验－DNA指纹技术4、代谢途径基因调控与中药材品质定向调控•初生代谢产物相同，以此为起点，产生各种各样成分，可阻断某一代谢途径，促进另一条代谢途径的产物积累•5、利用基因工程和组织培养技术，高效表达和生产天然活性成分•含量低，价钱贵的活性成分的生物生产（1）毛状根培养（2）生物转化6、基因工程与绿色无公害药用植物•（1）农药残留（2）重金属污染7、道地药材的形成机制研究道地性越明显，种群的基因特化就越明显。

分子生药学第一章绪论1945年，提出分子生物学一词1953年，发现DNA双螺旋模型1983年，提出聚合酶链式反应设想1985年，发明了聚合酶链式反应1995年，我国科学家黄璐琦院士首次提出了分子生药学概念1.分子生药学是在分子水平上研究中药的鉴定，质量的形成及活性成分生产的一门学科。

2.分子生药学的主要研究对象是生物来源药材。

3.分子生药学的任务:①从分子水平研究中药的鉴定②在分子水平研究中药的质量形成③中药活性成分的生物合成与生产第二章基本技术原理1变性：在过酸，过碱，加热等理化因素的作用下，DNA分子互补碱基对之间的氢键断裂，DNA双螺旋解链变成两条单链。

2.增色效应：在DNA解链过程中，260nm处的吸光度增加，增加量于解链程度呈一定的比例关系，称为DNA的增色效应3.复性：变性的DNA在适当条件下，两条互补链可以重新恢复天然的双螺旋构象。

4.退火：热变性的DNA在缓慢冷却时发生复性过程。

5.减色效应：在复性的过程中，DNA溶液的OD260值会减少。

6.去除杂质:①蛋白质和RNA的去除: 温浴结束后加入氯仿:异戊醇比为24 :1。

②多糖和淀粉的去除:如果提取物中多糖和淀粉含量高，可以利用其与DNA在不同盐溶液中的溶解性差异，去除多糖类杂质的目的。

③去除酚类物质。

在DNA提取缓冲液中加入防止分类氧化的试剂，如β-巯基乙醇，抗坏血酸，半胱氨酸，二流苏糖醇。

7.DNA质量检测纯的DNA沉淀为白色干后透明。

干后是白色，则说明蛋白质类杂质较多，若呈黄色至棕色，则含有多酚类杂质，若呈胶冻状，则含有多糖类杂质。

DNA质量检测的方法:①有紫外分光光度法(DNA在260nm处有最大吸收峰，蛋白质在280nm处有最大吸收峰)②琼脂糖凝胶电泳法。

8.聚合酶链式反应(PCR)（1）Kary Mullis在1985年提出，并在1993年获得诺贝尔奖。

（2）PCR模拟了DNA复制过程，其特异性主要体现在与靶序列两端互补的寡核苷酸引物上。